87 related articles for article (PubMed ID: 954816)
21. Blood serotonergic mechanisms in type 2 (non-insulin-dependent) diabetes mellitus.
Pietraszek MH; Takada Y; Takada A; Fujita M; Watanabe I; Taminato A; Yoshimi T
Thromb Res; 1992 Jun; 66(6):765-74. PubMed ID: 1519234
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of thrombin binding and serotonin secretion from platelets by a 74,000 dalton protein.
Ganguly P; Fossett NG
Biochem Biophys Res Commun; 1983 Apr; 112(1):228-34. PubMed ID: 6838608
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of human platelet functions by cyclandelate.
van den Hoven WE; Hall DW
Drugs; 1987; 33 Suppl 2():41-52. PubMed ID: 3304954
[TBL] [Abstract][Full Text] [Related]
24. Effect of fenfluramine on 5-hydroxytryptamine uptake and release by rat blood platelets.
Buczko W; De Gaetano G; Garattini S
Br J Pharmacol; 1975 Apr; 53(4):563-8. PubMed ID: 1148499
[TBL] [Abstract][Full Text] [Related]
25. Identification of alpha-adrenergic receptors in human platelets by [3H]dihydroergocryptine binding.
Newman KD; Williams LT; Bishopric NH; Lefkowitz RJ
J Clin Invest; 1978 Feb; 61(2):395-402. PubMed ID: 23392
[TBL] [Abstract][Full Text] [Related]
26. Effects of urapidil on 5-hydroxytryptamine induced platelet aggregation and on 14C-5-hydroxytryptamine uptake in platelets.
Storck J; Ochs JG; Kirsten R
Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):303-8. PubMed ID: 2387654
[TBL] [Abstract][Full Text] [Related]
27. Influence of clonidine-like hypotensive drugs on adrenergic platelet reactions.
Glusa E; Markwardt F
Biochem Pharmacol; 1981 Jun; 30(11):1359-60. PubMed ID: 6268096
[No Abstract] [Full Text] [Related]
28. Effect of sulphinpyrazone on human platelet aggregation, 5-hydroxytryptamine release and adhesion ex vivo: comparison with naproxen.
Nunn B; James FJ
Br J Clin Pharmacol; 1980 Mar; 9(3):239-45. PubMed ID: 7362733
[TBL] [Abstract][Full Text] [Related]
29. The fibrinogen-derived peptide (RGDS) prevents proteolytic degradation of protein kinase C in platelets by inhibiting platelet aggregation.
Krishnamurthi S; Dickens TA; Patel Y; Wheeler-Jones CP; Kakkar VV
Biochem Biophys Res Commun; 1989 Sep; 163(3):1256-64. PubMed ID: 2783136
[TBL] [Abstract][Full Text] [Related]
30. Re-evaluation of the uptake of desoxyfructo-serotonin by human platelets, and of its effect on the uptake of serotonin.
Costa JL; Kirk KL
Res Commun Chem Pathol Pharmacol; 1979 Jul; 25(1):79-88. PubMed ID: 451361
[TBL] [Abstract][Full Text] [Related]
31. Weak inhibition of protein kinase C coupled with various non-specific effects make sphingosine an unsuitable tool in platelet signal transduction studies.
Krishnamurthi S; Patel Y; Kakkar VV
Biochim Biophys Acta; 1989 Feb; 1010(2):258-64. PubMed ID: 2492201
[TBL] [Abstract][Full Text] [Related]
32. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
Hawiger J; Parkinson S; Timmons S
Nature; 1980 Jan; 283(5743):195-7. PubMed ID: 6985716
[TBL] [Abstract][Full Text] [Related]
33. The effects of protriptyline and clomipramine in vitro on the uptake of 5-hydroxytryptamine and dopamine in human platelet-rich plasma.
Trenchard A; Turner P; Pare CM; Hills M
Psychopharmacologia; 1975 Jul; 43(1):89-93. PubMed ID: 1161997
[TBL] [Abstract][Full Text] [Related]
34. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
Michal F; Motamed M
Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
[TBL] [Abstract][Full Text] [Related]
35. Role of chondroitin 4-sulphate as a receptor for polycation induced human platelet aggregation.
Donato JL; Marcondes S; Antunes E; Nogueira MD; Nader HB; Dietrich CP; Rendu F; de Nucci G
Br J Pharmacol; 1996 Dec; 119(7):1447-53. PubMed ID: 8968554
[TBL] [Abstract][Full Text] [Related]
36. Platelet deactivation by 5HT2-receptor blockade parallels the antihypertensive response to ketanserin.
Amstein R; Fetkovska N; Pletscher A; Bühler FR
J Hypertens; 1989 Apr; 7(4):255-60. PubMed ID: 2723427
[TBL] [Abstract][Full Text] [Related]
37. Desensitization and resensitization of human platelets to 5-hydroxytryptamine at the level of signal transduction.
Roevens P; de Chaffoy de Courcelles D
Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):775-82. PubMed ID: 7741708
[TBL] [Abstract][Full Text] [Related]
38. Age, platelet serotonin kinetics and 5HT2-receptor blockade in essential hypertension.
Amstein R; Fetkovska N; Bühler FR
J Hum Hypertens; 1990 Aug; 4(4):441-4. PubMed ID: 2258891
[TBL] [Abstract][Full Text] [Related]
39. Interactions of ethanol with ionophore A23187 in human platelets and erythrocytes and in rat brain slices.
Patrikiou-Caberos L; Lynch MA; Leroy C; Fenn GC; Littleton JM
Biochem Pharmacol; 1983 Jul; 32(14):2211-6. PubMed ID: 6409118
[TBL] [Abstract][Full Text] [Related]
40. Blood platelet adrenoceptor: aggregatory and antiaggregatory activity of imidazoline drugs.
Petrusewicz J; Kaliszan R
Pharmacology; 1986; 33(5):249-55. PubMed ID: 3797465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
